[1] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[2] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[3] |
ZHANG Yanjun, LI Jianchang, JIA Xiuhong, TIAN Chunmei.
Effects of FGFR inhibitor BGJ398 on cell biological behavior and drug resistance of leukemia cells
[J]. China Oncology, 2021, 31(3): 176-181.
|
[4] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[5] |
HE Hesheng , YANG Yuqiong , LIU Yinhua , JIN Xiaoke , XU Youhai , YAO Junping , LIU Shanhao , YAN Jiawei , HUANG Dongping .
Characteristic analysis of peripheral T-cell lymphoma associated with autoimmune hemolytic anemia
[J]. China Oncology, 2021, 31(2): 121-125.
|
[6] |
LI Lei , WANG Zhi , YOU Chunyuan .
The relapse of primary cardiac high-grade B-cell lymphoma after remission: a case report
[J]. China Oncology, 2021, 31(2): 156-160.
|
[7] |
LI Panpan, ZHANG Zhuo.
Analysis of prognostic factors in 42 cases of primary central nervous system lymphoma
[J]. China Oncology, 2021, 31(12): 1194-1201.
|
[8] |
YU Yi, CONG Qing, XU Congjian, JIANG Wei.
The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism
[J]. China Oncology, 2021, 31(11): 1063-1071.
|
[9] |
LIU Wei , WANG Xiaojiang , ZHANG Jing , ZHU Weifeng , PENG Fengying , WANG Jianchao , XIAO Weijin , HU Dan .
Clinicopathological characteristics and prognostic analysis of medullary thyroid carcinoma in children and adolescents
[J]. China Oncology, 2021, 31(11): 1096-1103.
|
[10] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[11] |
QIN Lingyan , GUO Lingchuan , GU Dongmei , YU Jie , YOU Zhiqun , HE Lu .
Cytopathological characteristics of pleural effusion in diagnosis of mediastinal diffuse large B-cell lymphoma
[J]. China Oncology, 2020, 30(9): 712-717.
|
[12] |
ZHANG Xiaohui , LUO Jianmin , SUO Xiaohui , SUN Guofeng , LIU Hongfeng , LI Jing , NIU Guangxu .
Relationship between epigenetic modification of SOCS1 and acute myeloid leukemia
[J]. China Oncology, 2020, 30(8): 577-585.
|
[13] |
YAN Fang, YING Mingzhen, CHEN Longpei, FU Qiang.
Clinical observation of albumin-bound paclitaxel plus nedaplatin as first-line treatment in advanced esophageal squamous cell carcinoma patients
[J]. China Oncology, 2020, 30(8): 632-635.
|
[14] |
ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang .
Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer
[J]. China Oncology, 2020, 30(7): 519-524.
|
[15] |
WANG Fang , WANG Xin , LIU Zhe , HUI Lingyun , FENG Ai , LI Na , WANG Yawen .
Inhibition of PDK1 induces apoptosis in CML cells via activation of ASK1/JNK/Bim cascade
[J]. China Oncology, 2020, 30(6): 401-406.
|